Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 17 of 17 entries
Sorted by: Best Match Show Resources per page
A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface.

Applied and environmental microbiology

Wood P, Jones M, Bhakoo M, Gilbert P.
PMID: 16535366
Appl Environ Microbiol. 1996 Jul;62(7):2598-602. doi: 10.1128/aem.62.7.2598-2602.1996.

Biofilms of a mucoid clinical isolate of Pseudomonas aeruginosa (24 h; ca. 10(sup6) CFU/cm(sup2)) were established by immersion of polymer discs in nutrient broth cultures at 37(deg)C. Biofilms exposed for 30 min to various concentrations (0 to 3 mg/ml)...

Cite
Wood P, Jones M, Bhakoo M, et al. A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface. Appl Environ Microbiol. 1996;62(7):2598-602doi: 10.1128/aem.62.7.2598-2602.1996.
Wood, P., Jones, M., Bhakoo, M., & Gilbert, P. (1996). A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface. Applied and environmental microbiology, 62(7), 2598-602. https://doi.org/10.1128/aem.62.7.2598-2602.1996
Wood, P, et al. "A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface." Applied and environmental microbiology vol. 62,7 (1996): 2598-602. doi: https://doi.org/10.1128/aem.62.7.2598-2602.1996
Wood P, Jones M, Bhakoo M, Gilbert P. A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface. Appl Environ Microbiol. 1996 Jul;62(7):2598-602. doi: 10.1128/aem.62.7.2598-2602.1996. PMID: 16535366; PMCID: PMC1388904.
Copy Download .nbib Format: NLM
Correction to: Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury.

Translational stroke research

Chen B, Ng G, Gao Y, Low SW, Sandanaraj E, Ramasamy B, Sekar S, Bhakoo K, Soong TW, Nilius B, Tang C, Robins EG, Goggi J, Liao P.
PMID: 30997597
Transl Stroke Res. 2020 Dec;11(6):1362-1363. doi: 10.1007/s12975-019-00705-y.

The original version of the article unfortunately contained an error.

Cite
Chen B, Ng G, Gao Y, et al. Correction to: Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury. Transl Stroke Res. 2020;11(6):1362-1363doi: 10.1007/s12975-019-00705-y.
Chen, B., Ng, G., Gao, Y., Low, S. W., Sandanaraj, E., Ramasamy, B., Sekar, S., Bhakoo, K., Soong, T. W., Nilius, B., Tang, C., Robins, E. G., Goggi, J., & Liao, P. (2020). Correction to: Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury. Translational stroke research, 11(6), 1362-1363. https://doi.org/10.1007/s12975-019-00705-y
Chen, Bo, et al. "Correction to: Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury." Translational stroke research vol. 11,6 (2020): 1362-1363. doi: https://doi.org/10.1007/s12975-019-00705-y
Chen B, Ng G, Gao Y, Low SW, Sandanaraj E, Ramasamy B, Sekar S, Bhakoo K, Soong TW, Nilius B, Tang C, Robins EG, Goggi J, Liao P. Correction to: Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury. Transl Stroke Res. 2020 Dec;11(6):1362-1363. doi: 10.1007/s12975-019-00705-y. PMID: 30997597; PMCID: PMC7852968.
Copy Download .nbib Format: NLM
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.

Liver international : official journal of the International Association for the Study of the Liver

Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S.
PMID: 34846800
Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30.

BACKGROUND: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH).PATIENTS AND METHODS: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes...

Cite
Efe C, Lammert C, Taşçılar K, et al. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int. 2021;doi: 10.1111/liv.15121.
Efe, C., Lammert, C., Taşçılar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., Calışkan, A. R., Peralta, M., Gerussi, A., Massoumi, H., Catana, A. M., Purnak, T., Rigamonti, C., Aldana, A. J. G., Khakoo, N., Nazal, L., Frager, S., Demir, N., Irak, K., Melekoğlu-Ellik, Z., Kacmaz, H., Balaban, Y., Atay, K., Eren, F., Alvares-da-Silva, M. R., Cristoferi, L., Urzua, �. �., Eşkazan, T., Magro, B., Snijders, R., Barutçu, S., Lytvyak, E., Zazueta, G. M., Demirezer-Bolat, A., Aydın, M., Heurgue-Berlot, A., De Martin, E., Ekin, N., Yıldırım, S., Yavuz, A., Bıyık, M., Narro, G. C., Kıyıcı, M., Akyıldız, M., Kahramanoğlu-Aksoy, E., Vincent, M., Carr, R. M., Günşar, F., Reyes, E. C., Harputluoğlu, M., Aloman, C., Gatselis, N. K., Üstündağ, Y., Brahm, J., Vargas, N. C. E., Güzelbulut, F., Garcia, S. R., Aguirre, J., Anders, M., Ratusnu, N., Hatemi, I., Mendizabal, M., Floreani, A., Fagiuoli, S., Silva, M., Idilman, R., Satapathy, S. K., Silveira, M., Drenth, J. P. H., Dalekos, G. N., N Assis, D., Björnsson, E., Boyer, J. L., Yoshida, E. M., Invernizzi, P., Levy, C., Montano-Loza, A. J., Schiano, T. D., Ridruejo, E., & Wahlin, S. (2021). Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15121
Efe, Cumali, et al. "Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15121
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30. PMID: 34846800.
Copy Download .nbib Format: NLM
Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis.

Liver international : official journal of the International Association for the Study of the Liver

Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Miranda Zazueta G, Demirezer Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Castro Narro G, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Cerda Reyes E, Harputoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Chris Escajadillo Vargas N, Güzelbulut F, Ruiz Garcia S, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, Assis DN, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S.
PMID: 34846800
Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30.

BACKGROUND: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH).PATIENTS AND METHODS: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes...

Cite
Efe C, Lammert C, Taşçılar K, et al. Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver Int. 2021;doi: 10.1111/liv.15121.
Efe, C., Lammert, C., Taşçılar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., Calışkan, A. R., Peralta, M., Gerussi, A., Massoumi, H., Catana, A. M., Purnak, T., Rigamonti, C., Gomez Aldana, A. J., Khakoo, N., Nazal, L., Frager, S., Demir, N., Irak, K., Melekoğlu Ellik, Z., Kacmaz, H., Balaban, Y., Atay, K., Eren, F., Alvares-da-Silva, M. R., Cristoferi, L., Urzua, �. �., Eşkazan, T., Magro, B., Snijders, R., Barutçu, S., Lytvyak, E., Miranda Zazueta, G., Demirezer Bolat, A., Aydın, M., Heurgue-Berlot, A., De Martin, E., Ekin, N., Yıldırım, S., Yavuz, A., Bıyık, M., Castro Narro, G., Kıyıcı, M., Akyıldız, M., Kahramanoğlu-Aksoy, E., Vincent, M., Carr, R. M., Günşar, F., Cerda Reyes, E., Harputoğlu, M., Aloman, C., Gatselis, N. K., Üstündağ, Y., Brahm, J., Chris Escajadillo Vargas, N., Güzelbulut, F., Ruiz Garcia, S., Aguirre, J., Anders, M., Ratusnu, N., Hatemi, I., Mendizabal, M., Floreani, A., Fagiuoli, S., Silva, M., Idilman, R., Satapathy, S. K., Silveira, M., Drenth, J. P. H., Dalekos, G. N., Assis, D. N., Björnsson, E., Boyer, J. L., Yoshida, E. M., Invernizzi, P., Levy, C., Montano-Loza, A. J., Schiano, T. D., Ridruejo, E., & Wahlin, S. (2021). Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15121
Efe, Cumali, et al. "Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15121
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Miranda Zazueta G, Demirezer Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Castro Narro G, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Cerda Reyes E, Harputoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Chris Escajadillo Vargas N, Güzelbulut F, Ruiz Garcia S, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, Assis DN, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver Int. 2021 Nov 30; doi: 10.1111/liv.15121. Epub 2021 Nov 30. PMID: 34846800.
Copy Download .nbib Format: NLM
Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model.

Journal of tissue engineering and regenerative medicine

Hu T, Liu L, Lam RWM, Toh SY, Abbah SA, Wang M, Ramruttun AK, Bhakoo K, Cool S, Li J, Cho-Hong Goh J, Wong HK.
PMID: 34687157
J Tissue Eng Regen Med. 2022 Jan;16(1):63-75. doi: 10.1002/term.3260. Epub 2021 Nov 01.

High doses bone morphogenetic protein 2 (BMP-2) have resulted in a series of complications in spinal fusion. We previously established a polyelectrolyte complex (PEC) carrier system that reduces the therapeutic dose of BMP-2 in both rodent and porcine spinal...

Cite
Hu T, Liu L, Lam RWM, et al. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model. J Tissue Eng Regen Med. 2021;16(1):63-75doi: 10.1002/term.3260.
Hu, T., Liu, L., Lam, R. W. M., Toh, S. Y., Abbah, S. A., Wang, M., Ramruttun, A. K., Bhakoo, K., Cool, S., Li, J., Cho-Hong Goh, J., & Wong, H. K. (2022). Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model. Journal of tissue engineering and regenerative medicine, 16(1), 63-75. https://doi.org/10.1002/term.3260
Hu, Tao, et al. "Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model." Journal of tissue engineering and regenerative medicine vol. 16,1 (2022): 63-75. doi: https://doi.org/10.1002/term.3260
Hu T, Liu L, Lam RWM, Toh SY, Abbah SA, Wang M, Ramruttun AK, Bhakoo K, Cool S, Li J, Cho-Hong Goh J, Wong HK. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model. J Tissue Eng Regen Med. 2022 Jan;16(1):63-75. doi: 10.1002/term.3260. Epub 2021 Nov 01. PMID: 34687157.
Copy Download .nbib Format: NLM
Showing 13 to 17 of 17 entries